Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer
European Journal of Cardio-Thoracic Surgery · 02.08.2024 · 66 (2)
DOI: 10.1093/ejcts/ezae300 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 09.08.2024. Verfasst von Meixin Teng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Pneumonectomy, Lung Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Innovation Program of Shanghai Municipal Education Commission, Shanghai Pulmonary Hospital.
Abstract (Originalsprache)
OBJECTIVES Neoadjuvant therapy has gained widespread acceptance as the standard modality for locally advanced non-small cell lung cancer. However, the clinical benefit of sleeve lobectomy (SL) or pneumonectomy (PN) following neoadjuvant therapy remains controversial. METHODS The clinical and pathological characteristics of non-small cell lung cancer patients who underwent SL or PN after neoadjuvant therapy at a high-volume single centre between December 2019 and March 2023 were retrospectively collected. The SL group was matched 4:1 with the PN group by propensity score matching. The surgical outcomes were systematically collected and analysed. RESULTS During a 5-year study period, the majority of patients (175 of 215, 81.4%) underwent the SL procedure, while 40 patients (18.6%) underwent PN. Following propensity score matching, the SL group exhibited lower postoperative arrythmia (4.8% vs 26.9%, P < 0.001), lower 30-day mortality (1.0% vs 7.7%, P = 0.046) and a shorter length of postoperative hospital stay (6.0 days vs 10.0 days, P < 0.001), compared with the PN group. In addition, no significant difference was observed between the two groups in terms of disease-free survival or overall survival (P = 0.977 and P = 0.913, respectively). CONCLUSIONS SL stands as a safe and feasible option for patients with centrally located non-small-cell lung cancer who have undergone neoadjuvant therapy, in comparison to PN. This finding suggests that SL remains the preferable choice when feasible in the context of the widespread utilization of neoadjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Thoracic Surgery, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Central Laboratory, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Ziyun Shen, Peng Zhang
Förderung
- Science and Technology Commission of Shanghai Municipality
- Innovation Program of Shanghai Municipal Education Commission
- Shanghai Pulmonary Hospital
- Beijing CSCO Clinical Oncology Research Foundation
Zitieren
APA
Teng, M., Yi, C., Yang, W., Zhang, J., Yao, W., Hu, S., Qing, Y., Ji, S., Shen, Z., & Zhang, P. (2024). Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery, 66(2). https://doi.org/10.1093/ejcts/ezae300
Vancouver
Teng M, Yi C, Yang W, Zhang J, Yao W, Hu S, et al. Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 2024;66(2). doi:10.1093/ejcts/ezae300
BibTeX
@article{Teng2024,
author = {Teng, Meixin and Yi, Chengxiang and Yang, Weiguang and Zhang, Jing and Yao, Wangchao and Hu, Shiqi and Qing, Yang and Ji, Shuyu and Shen, Ziyun and Zhang, Peng},
title = {Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {66},
number = {2},
doi = {10.1093/ejcts/ezae300}
}
EUVIMED